Encoded Therapeutics (Series F)
Funding Details
Awarder
Inbox
Date Award
September 9, 2026
Vertical
Biotechnology
Funding Amount
$275,000,000
Company Info
Market
Neurological Disorders
Location
South San Francisco, California, USA
Coinvestors
ARCH Venture Partners, Braidwell, Farallon Capital Management, GV, Illumina Ventures, Invus, Janus Henderson Investors, Matrix Capital Management, Nolan Capital, RTW Investments, SoftBank Vision Fund 2, Venrock
Company Description

Encoded Therapeutics is a clinical-stage biotechnology company developing one-time precision genetic medicines for severe monogenic and common neurological disorders. The company's vector engineering platform enables highly targeted and cell-type-selective control of gene expression in the brain and peripheral nervous system, allowing potent and precise modulation of disease-relevant genes to address underlying disease biology.

Links